MJT & Associates Financial Advisory Group Inc. Takes $131,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

MJT & Associates Financial Advisory Group Inc. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, Holdings Channel.com reports. The institutional investor purchased 250 shares of the healthcare conglomerate’s stock, valued at approximately $131,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Citizens National Bank Trust Department lifted its stake in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH raised its position in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after buying an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $515,000. Full Sail Capital LLC raised its position in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after buying an additional 33 shares during the period. Finally, Soros Fund Management LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $39,413,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In related news, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the transaction, the director directly owned 6,063 shares in the company, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 over the last quarter. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $280.69 on Monday. The stock has a market cap of $254.62 billion, a P/E ratio of 11.75, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. The company has a fifty day simple moving average of $301.58 and a 200-day simple moving average of $424.22. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.15%. UnitedHealth Group’s payout ratio is 37.02%.

Analyst Ratings Changes

Several analysts have recently commented on the stock. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Oppenheimer dropped their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Truist Financial dropped their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating for the company in a report on Wednesday, July 16th. Finally, Piper Sandler dropped their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a report on Tuesday, June 3rd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $392.29.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.